TurnerC.T.MillerH.C. and MosesL.E., eds. AIDS Sexual Behavior and Intravenous Drug Use. (Washington: National Academy Press, 1989).
2.
HullC.F.BettingerC.J.CallaherM.M., “Comparison of HIV-antibody Prevalence in Patients Consenting to and Declining HlV-antibody Testing in an STD Clinic”, JAMA, 260:935–938, (1988); KrasinskiK.BorkowskyW.BebenrothD., “Failure of Voluntary Testing for Human Immunodeficiency Virus to Identify Infected Parturient Women in a High-risk Population”, N. Engl. J. Med., 318:185, (1988).
3.
DonderoT.J.Jr.PappaioanouM.CurranJ.W., “Monitoring the Levels and Trends of HIV Infection: The Public Health Service's HIV Surveillance Program”, Public Health Rep, 103:213–220, (1988).
4.
World Health Organization, “Unlinked Anonymous Screening for the Public Health Surveillance of HIV Infections. Proposed International Guidelines”, (Geneva: World Health Organization, Global Programme on AIDS, 1989).
5.
45 CFR 46.1101 (b)(5).
6.
Centers for Disease Control, “HIV Seroprevalence Survey of Childbearing Women. Testing Neonatal Dried Blood Specimens on Filter Paper for HIV Antibody”, Draft, August 8, 1988.
7.
BayerR.LevineC.WolfS.M., “HIV Antibody Screening: An Ethical Framework for Evaluating Proposed Programs”, JAMA256 (1986): 1768–1774.
8.
Cal. Health and Safety Codes, Section 199.22 (a).
9.
New York Times, January 12, 1987.
10.
NY Pub. Health Law, Section 2781 (6).
11.
Maine Rev. Stats. Ann., title 5, Section 19203(5) (West Supp. 1988). Colorado Rev. Stats., Section 25-4-1405(8)(a) (III) Bradford Cum. Supp. 1988). Ill. Ann. Stats., Section 7308 (West 1988). Wisc. Stats. Ann., Public Health Section 146.025(2)(a)(II) (West Supp. 1987). N. Hamp. Rev. Stats., Public Health Section 141-F:5(III) (Equity Cum. Supp. 1988). Ind. Stats. Ann., Section 16-1-9.5–2.5(b) (Michie Cum. Supp. 1987). R.I. Gen. Laws, Section 26-6-12 (Michie Cum. Supp. 1988).
12.
DublerN.N.SidelV.W., “On Research on HIV Infection and AIDS in Correctional Institutions”, Milbank Quarterly (in press).
13.
New York Newsday 1989, July 27. p. 6.
14.
DollR., “A Proposal for Doing Prevalence Studies of AIDS”, Br Med J, 294 (1987): 244.
15.
GillonR., “Testing for HIV without Permission”, Br Med J, 294 (1987): 821–23.
16.
House of Commons, Social Services Committee Session 1986–87. Problems associated with AIDS, Vol. II: 296–305.
17.
Ibid., 16–32.
18.
House of Commons, Social Services Committee Session 1986–1987, problems associated with AIDS, Vol. I.xii.
19.
BlackD.BodnerW.CoxW., “HIV Testing on all Pregnant Women”, Lancet (1987): 1277.
20.
Department of Health and Social Security, “Report of a Working Group on the Monitoring and Surveillance of HIV Infection and AIDS”, May 1988.
21.
Lancet (1988): 1293.
22.
GillO.N.AdlerM.W. and DayN.E., “Monitoring the Prevalence of HIV Foundations for a Programme of Unlinked Anonymous Testing in England and Wales”, Br Med J, 299 (1989): 1295–98.
23.
DelamontheT., “Anonymous Testing for HIV”, Br Med J, 297(1988): 1425.
24.
Hull, Bettinger, Callaher, supra, note 2.
25.
HeptonstallJ.GillO.N., “The Legal and Ethical Basis for Unlinked Anonymous HIV Testing”, Communicable Disease Report (UK), 48 (1989): 3–6.
26.
Ibid.
27.
Gezondheidsraad. Permanente Commissie AIDS, “Onderzoek near de Verspreiding van HIV-infectie in Nederland [Studies on the spread of HIV-infections in the Netherlands] Gezondheidsraad”, ‘s-Gravenhage, 1989.
28.
Roscam Abbing HDC, “AIDS, Testen en Privacy”, in AIDS: Oorzaak en Gevolg, Nederlands Gesprekscentrum, ‘s-Gravenhage, 1988; 41–62.
29.
Vasle Kamerpommissle Voor de Volksgezondheid (Parliamentary Standing Committee For Health): UCV Pattientenbeleid, February 27, 1989.
30.
AkveldJ.E.M.HermansH.E.C.M., Anonieme Screening op HIV-Infecties. Juridische Aspecten (Rotterdam: Erasmus Universiteit, Juli 1989).
31.
LumeyL.H.HouwelingH.JagerJ.C., “Noodzaak en Mogelijkheden van Onderzoek naar de Prevalentie van HIV-infecties in Nederland”, Ned Tijdschr Geneeskd, 133 (1989): 923–38.
32.
Handelingen Tweede Kamer (Parliamentary Proceedings) Vergaderjaar 1989–1990: Het verworven Immuun deficientiessyndroom (AIDS). 1990, 19216, 39, 1–5.
33.
Nationale Commissie AIDS Bestrijding, Advies over Grootschalig HIV-seroprevalentie Onderzoek op Anonieme Basis (Amsterdam: Nationale Commissee AIDS Bestrijding, 1989).
34.
GeversJ.K.M., “Het Gebruik van Afgenomen Lichaamsmateriaal in Epidemiologisch Onderzoek”, Ned Tijdschr Geneeskd, 133 (1989): 173–75.
35.
KinzmanJ.DurbanJ.CoxD., “Statistical Requirements of the AIDS Epidemic”, J R Statist Soc, 151 (1988): 127–30.
36.
Government of Canada Federal AIDS Centre, Guidelines on Ethical and Legal Conditions in Anonymous Unlinked HIV Seroprevalence Research, May 1988.